Handelsbanken Fonder AB - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2021$626,000
-6.8%
17,1000.0%0.00%
-25.0%
Q2 2021$672,000
+96.5%
17,100
+41.3%
0.00%
+100.0%
Q1 2021$342,000
-11.6%
12,1000.0%0.00%0.0%
Q4 2020$387,000
-1.0%
12,1000.0%0.00%
-33.3%
Q3 2020$391,000
-16.5%
12,100
-28.8%
0.00%
+50.0%
Q2 2020$468,00017,0000.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GENERAL ATLANTIC, L.P. 4,000,000$67,760,0001.05%
M&G INVESTMENT MANAGEMENT LTD 7,084,834$120,442,1780.54%
Bellevue Group AG 1,802,963$30,584,7610.49%
AIA Group Ltd 391,278$6,628,2490.32%
PLATINUM INVESTMENT MANAGEMENT LTD 182,052$3,083,9610.12%
SCHRODER INVESTMENT MANAGEMENT GROUP 4,219,168$71,472,7060.11%
Hennion & Walsh Asset Management, Inc. 51,735$876,3910.06%
Allianz Asset Management GmbH 1,644,999$27,866,2830.05%
Janney Capital Management LLC 17,203$2910.02%
ACADIAN ASSET MANAGEMENT LLC 193,811$3,2680.01%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders